2m 2m 2m 2m 2m 2m 2m
CEL-SCI (CVM)
NYSE
$1.02+$0.002 (+0.20%)
Price as of Jun 23, 2026 7:24 PM EDT- $17.7MMarket Cap
- -58.02%1-Year Change
- BiotechnologyIndustry
CEL-SCI (CVM)
$1.02+$0.002 (+0.20%)
CVM | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $1.02 | ||
Change | +$0.01 (+0.99%) | ||
Open | $1.01 | ||
High | $1.04 | ||
Low | $1.00 | ||
Previous Close | $1.01 | ||
Volume | 189,883 | ||
30-Day Average Volume | 345,339 | ||
1-Week Change | 0.99% | ||
1-Month Change | -28.17% | ||
1-Year Change | -58.02% | ||
3-Year Change | -98.53% | ||
5-Year Change | -99.85% | ||
Fundamentals | |||
Shares Outstanding | 17.5M | ||
Total Assets | $17.7M | ||
Market Cap | $17.7M | ||
Enterprise Value | $15.8M | ||
Period: QTR TTM FY | |||
Revenue | -$117,485.00 | ||
Net Income | -$5.5M | ||
Free Cash Flow | -$4.0M | ||
EBIT | -$5.3M | ||
EBITDA | -$4.4M | ||
Net Working Capital | -$1.9M | ||
EPS | -$0.67 | ||
Enterprise Value/EBITDA | -4 | ||
Enterprise Value/Revenue | -134 | ||
P/B | 3 | ||
P/E | -2 | ||
PEG | -1 | ||
Price/Free Cash Flow | -4 | ||
Price/Operating Cash Flow | -4 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 30 | ||
Last Split Date | 05/20/2025 | ||
Earnings & Revenue